Share:
Non-Malaysian citizens are subject to 6% SST, to be verified and paid at the counter before screening.
EBV Test for Nasopharyngeal Carcinoma (NPC)
Introduction
The EBV (Epstein-Barr Virus) test is an important screening tool for nasopharyngeal carcinoma (NPC). EBV is closely linked with NPC development. Testing EBV antibodies or EBV DNA helps evaluate an individual's cancer risk.
EBV antibody tests are commonly used for screening, while EBV DNA tests provide higher sensitivity and specificity for diagnosis and monitoring.
Why Take an EBV Test?
- Early screening: Detects potential risk before obvious symptoms.
- Risk assessment: Evaluates individual risk considering family history and epidemiology.
- Diagnostic support: EBV DNA levels assist in diagnosis and staging.
- Follow-up monitoring: Used in NPC patients to track recurrence after treatment.
Method & Workflow
A venous blood sample is collected to test for EBV antibodies (e.g., VCA-IgA, EA-IgA) or EBV DNA. Results should always be interpreted with imaging (nasopharyngoscopy, MRI, CT) and clinical evaluation.
Factors & Notes
- Not all EBV infections lead to NPC.
- Antibody levels vary depending on infection stage and individual immunity.
- Comprehensive evaluation with family history, symptoms, and imaging is necessary.
Who Should Consider Testing?
- Individuals with a family history of nasopharyngeal carcinoma
- High-risk populations (e.g., Southern Chinese ethnicity)
- Patients with persistent nasal obstruction, epistaxis, or enlarged neck lymph nodes
- NPC patients under post-treatment surveillance
Frequently Asked Questions (FAQ)
Q1: Does EBV infection always lead to nasopharyngeal carcinoma?
A: No. While EBV infection is common, only a small portion of high-risk individuals develop NPC.
Q2: What is the difference between EBV antibody and EBV DNA testing?
A: Antibody testing is often used for mass screening, while DNA testing is more suitable for diagnosis and follow-up.
Q3: Who should undergo regular EBV testing?
A: Individuals with family history or living in high-risk regions should consider regular screening under medical advice.
Inquiry - Nasopharyngeal Carcinoma Screening (EBV VCA IgA)
